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1. Introduction 
Kawasaki disease (KD) is an acute febrile illness of early childhood that is characterized 
by high fever, bilateral conjunctivitis, redness of the oral mucosa, polymorphous skin 
rash, indurative edema of the hands and feet, and cervical lymphadenopathy (Kawasaki, 
1967). The major pathological lesion of KD is vasculitis of small and medium-sized 
arteries (Amano et al., 1979). The coronary arteries are the most severely affected and 
coronary artery lesions (CALs) occur in 15–25% of untreated patients (Kato et al., 1975), 
making KD a leading cause of childhood acquired heart disease in developed countries. 
The fact that the peak incidence of KD is at 9–11 months of age, which coincides with the 
waning of maternal immunity, indicates that infections could contribute to the 
pathogenesis of KD. However, despite more than 40 years of intensive research, the 
causative microorganism of KD remains unknown. On the other hand, epidemiological 
studies have revealed a significant role of genetic components in host susceptibility to KD 
pathogenesis. 
2. Epidemiological features of KD suggesting a genetic predisposition 
Since the first description of KD (Kawasaki, 1967) more than four decades ago, biannual 
epidemiological surveys conducted in Japan and epidemiological studies performed in 
almost all ethnic groups during this period have highlighted the contribution of genetic 
factors in the pathogenesis of KD. 
2.1 Ethnic differences in the incidence of KD 
KD is much more prevalent in East Asia than in any other countries of the world. In 
Japan, its incidence was 218.6 per 100,000 children younger than 4 years old in 2008 and 
continues to rise (Nakamura et al., 2010). Its incidence in Korea and Taiwan, the 
neighboring countries to Japan, are the second (113.1) and third (69.0) highest, 
respectively (Huang et al., 2009; Park et al., 2011). The incidence of KD in Western 
countries is 10–20 times lower than in Japan. Recent surveillance of KD in Hawaii 
revealed that Asian children, especially those of Japanese ancestry, had the highest 
incidence (210.5), and that the incidence among Caucasian children in Hawaii (13.7) was 
similar to that of the continental United States (Holman et al., 2010). These facts indicate 
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that the high incidence of KD in East Asian countries is due to the racial/ethnic genetic 
background rather than to geographic factors.  
2.2 Individual susceptibility to KD 
In Japan, a total of 20 nationwide biannual continued surveillances of KD have been carried 
out since 1970. Epidemiological evidence collected from these surveys suggested individual 
susceptibility to KD, which was mainly composed of multiple genetic factors. For example, 
sibling cases of KD have a ≥10 times higher incidence than expected (Fujita et al., 1989). In 
addition, parents of KD patients, who were affected by KD during their childhood, were 
observed 2 times more often than expected (Uehara et al., 2003).  
3. Genetic studies of KD 
KD is considered to be a multifactorial disease that is caused by the interplay of external and 
personal factors (Fig. 1). Thus, identification of the responsible genetic factors, which 
presumably determine an individual’s susceptibility to KD, should provide clues to the 
pathogenesis of the disease. Furthermore, it could contribute to the development of  
novel clinical applications, such as a severity prediction method and new therapeutic 
measures.     
 
 
Fig. 1. Multiple factors that are linked to KD. 
3.1 Candidate gene studies  
KD is an immune-mediated vasculitis syndrome; therefore, genes encoding proteins related 
to innate and acquired immune function or to vascular remodeling could be involved in its 
pathogenesis, response to treatment, and prognosis. Variations within such “candidate 
genes” have been extensively studied. 
3.1.1 Human leukocyte antigen (HLA) genes 
Genetic studies of KD were initially conducted by focusing on the HLA class I genes, and 
several serotypes of the HLA-B locus have been associated with KD in different ethnic 
groups (Table 1).  
www.intechopen.com
 
Responsible Genetic Factors for Vasculitis in Kawasaki Disease 
 
73 
Recently, significant associations of single nucleotide polymorphisms (SNPs) within the 
HLA-G and HLA-E genes were reported (J.J. Kim et al., 2008; Y.J. Lin et al., 2009). However, 
most of the previous studies, including those describing negative association results, were 
conducted by analyzing a relatively small number of cases and controls, while replication 









HLA-B Bw22J Serotyping 
Japanese 
(32/76) 





Kato et al., 1978 
HLA-B Bw15 
HLA-B Bw51 Serotyping 
Caucasian 
(23/244) 
Krensky et al., 1981 
HLA-B Bw51 Serotyping 
Jewish 
(12/90) 
Keren et al., 1982 
HLA-B Bw44 Serotyping 
Caucasian 
(23/246) 
Krensky et al., 1983 
HLA-B Bw44 Serotyping 
Caucasian 
(16/608) 





Oh et al., 2008 HLA-B B75 
HLA-C Cw09 
HLA-DRB3 DRB3*0301 Genotyping 
Caucasian 
(21/200) 
















Y.J. Lin et al., 2009 
Table 1. Association studies between HLA genes and KD. 
3.1.2 Non-HLA genes 
Advances from the Human Genome and Hapmap projects have dramatically reduced the 
effort and cost of conducting genetic association studies of complex diseases, leading to a 
recent increase in the number of candidate gene studies, especially since 2005 (Table 2). 
Among the genes studied, tumor necrosis factor (TNF), which is a proinflammatory 
cytokine deeply related to the pathogenesis of KD, has been most frequently analyzed. 
Although many of these studies have failed to identify a statistically significant association, 
a systematic meta-analysis revealed a trend of association between the G allele of rs180629, 
which is located 308 bases upstream of the TNF gene, and KD (Ari-Ong et al., 2010). 
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Gene Chromosomal region 
Reference 
Associated Not associated 
Cytokines, chemokines, and their receptors 
IL-10 1q31-q32 Hsueh et al., 2009 
Jin et al., 2007 
Weng et al., 2010a 
TGFB2 1q41 Shimizu et al., 2011  
IL-1 2q14  Weng et al., 2010b 
S.K. Kim et al., 2011 
IL-1 2q14  
S.F. Wu et al., 2005 
Weng et al., 2010b 
S.K. Kim et al., 2011 
IL-1Ra 2q14.2 S.F. Wu et al., 2005 
Weng et al., 2010b 
S.K. Kim et al., 2011 
CXCR2 2q35  Breunis et al., 2007 
CXCR1 2q35  Breunis et al., 2007 
TGFBR2 3p22 Shimizu et al., 2011  
CX3CR1 3p21.3  Breunis et al., 2007 
CCR3 3p21 Breunis et al., 2007  
CCR2 3p21 Breunis et al., 2007  
CCR5 3p21 
Burns et al., 2005 
Jhang et al., 2009 
Breunis et al., 2007 
Mamtani et al., 2010 
Chaudhuri et al., 2011 
IL-8 4q13-q21  Weng et al., 2010b 
IL-4 5q31.1 Burns et al., 2005 
S.F. Wu et al., 2005 
F.Y. Huang et al., 2008a 
Weng et al., 2010b 
LTA 6p21.3 Quasney et al., 2001  
TNF- 6p21.3 Cheung et al., 2008 
Kamizono et al., 1999 
Quasney et al., 2001 
Ahn et al., 2003 
Chien et al., 2003 
Weng et al., 2010b 
IL-6 7p21  
Sohn et al., 2001 
Weng et al., 2010b 
IL-18 11q22.2-q22.3 
Hsueh et al., 2008a 
Chen et al., 2009 
 
TNFRSF1A 12p13.2 Wang et al., 2011  
MCP1 17q11.2-q12  Jibiki et al., 2001 
CCL5 17q11.2-q12  Chaundhuri et al., 2011 
CCL3L1 17q11.2 
Burns et al., 2005 
Mamtani et al., 2010 
 
TGFB1 19q13.1  Weng et al., 2010b 
MIF 22q11.2  Simonini et al., 2009 
Vasoactive molecules or molecules related to vascular remodeling 
AGTR1 3q21-q25  Fukazawa et al., 2004 
TIMP4 3p25  Ban et al., 2009 
VEGFR2 4q12  Kariyazono et al., 2004 
VEGFA 6p12 
Breunis et al., 2006 
Hsueh et al., 2008b 
Kariyazono et al., 2004 
F.Y. Huang et al., 2008b 
eNOS 7q36  Khajoee et al., 2003 
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MMP26 11p15  Ban et al., 2010 
MMP7 11q21-22  Ban et al., 2010 
MMP3 11q22.3  
J.A. Park et al., 2005 
Ikeda et al., 2008 
Hong et al., 2008 
MMP12 11q22.3  
Ikeda et al., 2008 
Ban et al., 2010 
MMP13 11q22.3  Ikeda et al., 2008 
MMP2 16q13-q21  Ikeda et al., 2008 
iNOS 17q11.2-q12  Khajoee et al., 2003 
ACE 17q23 
S.F. Wu et al., 2004 
Shim et al., 2006 
Fukazawa et al., 2004 
TIMP2 17q25  Furuno et al., 2007 
MMP9 20q11.2-q13  
J.A. Park et al., 2005 
Ikeda et al., 2008 
MMP11 22q11.2 Ban et al., 2010  
Molecules related to innate immune functions 
CRP 1q21-q23 Cheung et al., 2008  
SLC11A1 2q35 Ouchi et al., 2003  
CD14 5q31.1  Nishimura et al., 2003 
MBL 10q11.2-q21 Biezeveld et al., 2003 Cheung et al., 2004 
Molecules related to acquired immune functions 
FCGR2A 1q23  
Taniuchi et al., 2005 
Biezeveld et al., 2007 
FCGR2B 1q23  Biezeveld et al., 2007 
FCGR3A 1q23 Taniuchi et al., 2005 Biezeveld et al., 2007 
FCGR3B 1q23  
Taniuchi et al., 2005 
Biezeveld et al., 2007 
CTLA4 2q33  Kuo et al., 2010 
PD-1 2q37.3 Chun et al., 2010  
MICA 6p21.3 F.Y. Huang et al., 2000  
BTNL2 6p21.3 Hsueh et al., 2010  
CD40L Xq26  
Y. Onouchi et al., 2004 
F.Y. Huang et al., 2008c 
Others 
MTHFR 1p36.3 Tsukahara et al., 2000  
UGT1A1 2q37  Kanai et al., 2003 
BAT2, 3, 5 6p21.3 Hsieh et al., 2010  
NOTCH4 6p21.3  Kang et al., 2011 
COL11A2 6p21.3 Shue et al., 2010  
ITPR3   Y.C. Huang et al., 2010 
PAFAH 6p21.2-p12  Minami et al., 2005 
TPH2 12q21.1  S.W. Park et al., 2010 
SMAD3 15q22.33 Shimizu et al., 2011  
MEFV 16p13  Yamaguchi et al., 2009 
HMOX1 22q12  Kanai et al., 2003 
Table 2. Association studies between polymorphisms of candidate genes and KD. 
The association of these candidate SNPs and patient response to intravenous immunoglobulin 
(IVIG) therapy and the development of CALs has also been studied (Table 3). 
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Association No association 
MTHFR CAL Tsukahara et al., 2000  
CRP 
CAL  Cheung et al., 2008 
Intima-media 
thickness 
Cheung et al., 2008  
Arterial stiffness Cheung et al., 2008  
IL-10 
CAL Jin et al., 2007 Hseuh et al., 2009 
Serum albumin Jin et al., 2007  
FCGR2A CAL Taniuchi et al., 2005 Biezeveld et al., 2007 
FCGR2B CAL  Biezeveld et al., 2007 
FCGR3A CAL  
Taniuchi et al., 2005 
Biezeveld et al., 2007 
FCGR3B CAL  
Taniuchi et al., 2005 
Biezeveld et al., 2007 
TGFB2 
CAL/ 
coronary z score 
Shimizu et al., 2011  
Diameter of aortic 
root 
Shimizu et al., 2011  
Response to IVIG Shimizu et al., 2011  
IL-1 CAL  S.K. Kim et al., 2011 
IL-1 Response to IVIG Weng et al., 2010 S.K. Kim et al., 2011 
IL-1Ra CAL  S.K. Kim et al., 2011 
CTLA4 CAL Kuo et al., 2010  
PD-1 CAL  Chun et al., 2010 
TIMP4 CAL Ban et al., 2009  
TGFBR2 
CAL/ 
coronary z score 
Shimizu et al., 2011  
Diameter of aortic 
root 
Shimizu et al., 2011  
Response to IVIG Shimizu et al., 2011  
CCR5 CAL 
Mamtani et al., 2010 
Chaudhuri et al., 2011 
Jhang et al., 2009 
AGTR1 Coronary stenosis Fukazawa et al., 2004  
VEGFR2 CAL Kariyazono et al., 2003  
IL-4 CAL  
Burns et al., 2005 
F.Y.Huang et al., 2008a 
CD14 CAL Nishimura et al., 2003  
VEGFA CAL Kariyazono et al., 2003 
Hsueh et al., 2008b 
F.Y.Huang et al., 2008b 
MICA CAL F.Y. Huang et al., 2000  
LTA CAL  Quasney et al., 2001 
TNF- CAL Quasney et al., 2001 Cheung et al., 2008 
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Arterial stiffness Cheung et al., 2008  
BAT2, 3, 5 CAL Hsieh et al., 2010  
NOTCH4 CAL  Kang et al., 2011 
BTNL2 CAL Hsueh et al., 2010  
COL11A2 CAL Shue et al., 2010  
ITPR3 
CAL Y.C. Huang et al., 2010  
CRP Y.C. Huang et al., 2010  
PAFAH CAL  Minami et al., 2005 
PAFAH Response to IVIG Minami et al., 2005  
eNOS CAL  Khajoee et al., 2003 
MBL 
CAL 
Biezeveld et al., 2003 
Biezeveld et al., 2006 
Cheung et al., 2004 
Arterial stiffness Cheung et al., 2004  
MMP26 CAL  Ban et al., 2010 
IL-18 CAL  Hsueh et al., 2008a 
MMP7 CAL  Ban et al., 2010 
MMP3 CAL J.A. Park et al., 2005 
Ikeda et al., 2008 
Hong et al., 2008 
MMP12 CAL  
Ikeda et al., 2008 
Ban et al., 2010 
MMP13 CAL Ikeda et al., 2008  
TPH2 CAL S.W. Park et al., 2010  
SMAD3 
CAL/ 
coronary z score 
Shimizu et al., 2010  
Diameter of aortic 
root 
Shimizu et al., 2010  
Response to IVIG Shimizu et al., 2010  
MEFV CAL  Yamaguchi et al., 2009 
MMP2 CAL  Ikeda et al., 2008 
iNOS CAL  Khajoee et al., 2003 
CCL3L1 
CAL  Mamtani et al., 2010 
Response to IVIG Mamtani et al., 2010  
CCL% CAL  Chaundhuri et al., 2011 
ACE 
CAL Takeuchi et al., 1997 
S.F. Wu et al., 2004 
Shim et al., 2006 
Coronary stenosis Fukazawa et al., 2004  
TIMP2 CAL Furuno et al., 2007  
MMP9 CAL  
J.A. Park et al., 2005 
Ikeda et al., 2008 
MIF CAL Simonini et al., 2009  
MMP11 CAL  Ban et al., 2010 
CD40L CAL Y. Onouchi et al., 2004 Huang et al., 2008c 
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3.2 Genome-wide studies 
In contrast to candidate gene studies, which are based on an assumption of the underlying 
cause of the disease, a strategy to identify disease-causing mutations or variations from the 
whole genome relies solely on positional information and was originally developed to map 
and identify the genes for Mendelian disorders. This genome-wide strategy has been 
adapted for complex diseases and has become the most reliable tool to identify disease-
related genes following the completion of the Human Genome Project.  
3.2.1 Linkage study 
The first genome-wide study for KD was conducted by our group (Y. Onouchi et al., 2007). 
In this study, 399 microsatellite marker alleles that were shared identical by descent between 
78 affected KD sib-pairs were analyzed, and 10 chromosomal regions linked with the 
disease were identified (Fig. 2). 
 
 
Fig. 2. Results from an affected sib-pair study (Y. Onouchi et al., 2007). Arrows indicate 
those chromosomal regions with a maximum LOD score (MLS) >1.0. 
3.2.1.1 Linkage disequilibrium mapping 
We narrowed down the candidate regions identified in the sib-pair study with a case–
control association study using “tagging” SNPs. Chunks of genomic regions containing the 
associated tagging SNPs were extensively analyzed by re-sequencing and a further 
association study. We identified a SNP that was associated with KD in both the Japanese 
and US populations (Y. Onouchi et al., 2008) (Table 4). The SNP, rs28493229, is located in 
intron 1 of the inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) gene, which catalyzes the 


















P value2 P value 
G/C 0.23 0.15 
1.89 (1.53 – 2.33) 
209 64:30 
2.13 (1.38 – 3.29) 
2.2x10-9 0.00045 
Table 4. Association of rs28493229 with KD. 1Risk allele is underlined. 2Dominant 
inheritance model. 3Transmitted:untransmitted ratio. TDT: transmission disequilibrium test, 
OR: odds ratio, CI: confidence interval. 
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The at-risk allele of rs28493229 (C) reduces the splicing efficiency of ITPKC (Fig. 3). 
Transcripts with an unspliced intron are not properly translated because of premature 
termination. An increase in the number of such immature transcripts might lead to reduced 
ITPKC activity. IP3 is a second messenger molecule of the Ca2+/NFAT pathway in a wide 
variety of cells and, in mammals, 3 iso-enzymes (ITPKA, ITPKB, and ITPKC) have been 
identified with the same enzyme activity. 
 
 
Fig. 3. Functional significance of rs28493229 on ITPKC mRNA. 
Knockdown and overexpression experiments of ITPKC in the Jurkat cell line result in 
increased and decreased NFAT activity, respectively, as well as the expression of interleukin 
2 mRNA. These findings highlighted the importance of the Ca2+/NFAT pathway in the 
pathogenesis of KD. The association with the at-risk SNP allele was higher in KD patients 
with CAL than in those without CAL in both the Japanese and US populations. The same 
trend was also observed in KD patients in the US who responded poorly to intravenous 
immunoglobulin (IVIG) therapy. Two replication studies for the association of this SNP to 
KD, one negative and one positive, have been reported in the Taiwanese population (Chi et 
al., 2010; M.T. Lin et al., 2011). In the positive report, the SNP was also associated with the 
reactivation of previous BCG inoculation sites (M.T. Lin et al., 2011). 
3.2.1.2 Positional candidate gene analysis 
From the candidate region of chromosome 4, we identified the susceptibility gene via a 
different approach. The caspase-3 gene, which is located at 185.8 Mb, close to the linkage 
peak at 184.9 Mb, was focused on and studied as a positional candidate gene (Y. Onouchi et 
al. 2010). Multiple SNPs around the gene in linkage disequilibrium were associated with KD 
in the Japanese and US Caucasian populations. The functional SNP (rs72689236 G/A) was 
located in the 5′-untranslated region of the gene, and the risk allele (A) reduces the enhancer 
activity around the SNP to which NFATc2 is related (Table 5, Fig. 4).  
Caspase-3 is an effector caspase with a central role in apoptosis. T cells from caspase-3-
deficient mice have a reduced susceptibility to activation-induced cell death (Woo et al, 
1998). It was also reported that caspase-3 cleaves Nfatc2 as a substrate (W. Wu et al, 2006). 
Transient anergy of peripheral T cells in the convalescent phase of KD, which has been 
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documented in a couple of reports, is suggestive because the NFAT-driven expression of 
caspase-3 in T cells is related to T cell anergy (Macián et al., 2002). Currently, only one 
replication study has examined the association between rs72689236 and KD (Kuo et al, 
2011). Although not statistically significant, the same trend of association was observed in 
the Taiwanese population. Notably, in this report, the SNP was associated with increased 


















P value2 P value 




4.2 × 10-9 0.0037 
Table 5. Association of rs72689236 with KD. 1Risk allele is underlined. 2Allelic model. 




Fig. 4. Functional significance of rs72689236 on caspase-3 mRNA. 
3.2.2 Genome-wide association studies (GWAS) 
Today, GWAS using platforms by which 5.0 × 105 to 1 × 106 SNPs can be genotyped at a 
time have become commonplace for the analysis of complex disorders. GWAS for KD have 
been performed in 3 different ethnic groups: Caucasian, Korean, and Taiwanese (Burgner et 
al., 2009; J.J. Kim et al., 2011; Tsai et al., 2011). The number of subjects and SNPs analyzed in 
each study are summarized in Table 6.  
Although many candidate SNPs were identified, no locus was repeatedly associated with 
KD in these studies (Table 7). Considering that none of these associations fulfilled the 
genome-wide level significance threshold, further validation of the association at each locus 
within the same populations is essential. 
www.intechopen.com
 










Caucasian 119/135 583/13571 223,922 Burgner et al., 2009 
Korean 186/600 266/600 641,760 J.J. Kim et al., 2011 
Korean 63/600 2 86/6002 641,760 J.J. Kim et al., 2011 
Taiwanese 250/446 208/366 723,638 Tsai et al., 2011 
Table 6. Summary of GWAS for KD (I). 1583 KD patients and their unaffected siblings and 
biological parents. 2KD patients with coronary artery lesions and healthy controls.  
 
SNP Chr Position P value Gene Reference 
rs527409 1 58,757,915 1.5 × 10-6 DAB1 J.J. Kim et al., 2011 
rs952354 1 63,549,282 3.1 × 10-5 - * J.J. Kim et al., 2011 
rs7604693 2 64,349,202 2.0 × 10-6 PELI1 * J.J. Kim et al., 2011 
rs10183521 2 123,762,542 9.5 × 10-5 - Burgner et al., 2009 




Tsai et al., 2011 
rs9834548 3 165,139,947 9.8 × 10-6 - Burgner et al., 2009 
rs17531088 3 174,893,775 1.1 × 10-6 NAALADL2 Burgner et al., 2009 
rs3773986 3 190,278,915 6.2 × 10-5 IL1RAP * J.J. Kim et al., 2011 
rs4864471 4 54,426,184 3.4 × 10-5 
LNX1, 
LOC441016 
Burgner et al., 2009 
rs13128867 4 138,840,995 2.2 × 10-5 SLC7A11 Tsai et al., 2011 
rs149481 5 96,114,346 4.6 × 10-5 ERAP1 Tsai et al., 2011 
rs9392158 6 7,427,350 8.5 × 10-5 RIOK1 Burgner et al., 2009 
rs9364166 6 72,106,622 9.8 × 10-5 
OGFRL1, 
C6orf155 
J.J. Kim et al., 2011 
rs362794 7 103,201,263 3.0 × 10-5 RELN Tsai et al., 2011 
rs6469101 8 108,252,238 5.4 × 10-5 ANGPT1 Burgner et al., 2009 
rs328879 9 107,789,252 1.2 × 10-5 - Burgner et al., 2009 
rs10984642 9 122,450,340 2.6 × 10-5 - Burgner et al., 2009 
rs10984642 9 122,450,340 5.8 × 10-5 - Burgner et al., 2009 
rs4918458 10 111,505,407 9.8 × 10-5 - * J.J. Kim et al., 2011 
rs285032 13 98,786,532 1.7 × 10-5 FARP1 Burgner et al., 2009 
rs34246750 14 52,868,757 4.8 × 10-5 
PTGER2, 
TXNDC16 
J.J. Kim et al., 2011 
rs10129255 14 107,176,213 6.8 × 10-6 IGHV Tsai et al., 2011 
rs1568657 15 83,726,179 6.6 × 10-6 BTBD1 Tsai et al., 2011 
rs7199343 16 73,009,024 2.4 × 10-6 ZFHX3 Burgner et al., 2009 
rs8059315 16 74,506,447 8.5 × 10-5 GLG1 Burgner et al., 2009 
rs2270133 17 61,473,325 4.6 × 10-5 TANC2 * J.J. Kim et al., 2011 
Table 7. Summary of GWAS for KD (II). * Association was observed between KD patients 
with CAL and healthy controls. Chr: chromosome. 
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4. Clinical implementation of genetic findings 
The standard treatment for KD is a combination of oral aspirin and high-dose IVIG (Z. 
Onouchi & Kawasaki, 1999). While the majority of patients respond to this therapy, around 
15% are resistant and require additional IVIG or alternative drugs to prevent the 
development of CAL. As the etiology and pathophysiology of KD are largely unknown, the 
mechanism of action of these therapies on the disease is not fully understood. The 
identification of genetic factors that influence patient response to therapy might provide an 
insight to this problem.  
 
 
Fig. 5. Possible role of ITPKC and caspase-3 in the immune response. 
CRAC: calcium release-activated calcium channel, GPCR: G-protein-coupled receptor, FCGR: Fc gamma 
receptor, BCR: B cell receptor, TCR: T cell receptor, NFAT: nuclear factor of activated T cells, PLC: 
phospholipase, PIP2: phosphatidylinositol 4,5-bisphosphate, DAG: diacylglycerol, CALM: calmodulin, 
IP3R: IP3 receptor, ER: endoplasmic reticulum. 
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We investigated the association between the functional SNPs in the ITPKC and caspase-3 
genes with IVIG unresponsiveness and CAL formation, and found that patients with at least 
1 susceptible allele at both SNPs had 2.7–2.9 times higher risk for these unfavorable events 
(manuscript submitted). Considering that ITPKC and caspase-3 are possibly negative 
regulators of the Ca2+/NFAT pathway (Fig. 5), hyperactivation of the pathway might 
underlie a more severe clinical manifestation of the disease.  
From this point of view, Cyclosporine A, an immunosuppressant drug which potently 
suppresses the activity of T cells by targeting calcineurin, a key molecule of the Ca2+/NFAT 
pathway (Fig. 5), may be a good option for refractory cases of KD. In Japan, a study to 
investigate the tolerability, safety, and efficacy of Cyclosporine A for KD has been started. 
5. Conclusion 
Many candidate variations for susceptibility to KD have been reported from candidate gene 
and genome-wide studies; however, most of the findings from these studies are not robust 
and have yet to be confirmed by replication studies. Considering the modest odds ratios 
observed in recent GWAS for complex disorders, discovery studies should be conducted 
with much larger cohorts. Replication studies in different ethnic groups should be designed 
with careful attention to their power to detect a significant association and, most 
importantly, to the difference in the linkage disequilibrium structure. As the majority of KD 
patients are infants and children and the disease incidence is low, especially in countries 
outside East Asia, there are limitations in collecting subjects. In an attempt to overcome this 
difficulty, several consortia have been formed. Those engaged in KD research hope to 
unravel the mystery of this vasculitis and save these children from damage to their heart. 
We wish to contribute to this important mission by identifying the underlying genetic 
components of this disease. 
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